Efficacy of a Carbohydrate Drink on Speed, Agility and Power in School Going Children
NCT ID: NCT02428127
Last Updated: 2018-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2015-05-01
2015-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Carbohydrates From Nutritional Beverages in Children
NCT01355601
Carbohydrate Mouth Rinse (Small-Sided Soccer Games)
NCT06990022
Preoperative Two Hours Carbohydrate Load On Pediatric Patient Undergoing Elective Surgery
NCT06833671
Speed of Glucose Absorption
NCT06375577
Glucose:Fructose Versus Glucose Carbohydrate Ingestion and Endurance Performance
NCT02031783
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test
20g Carbohydrate powder fortified with multiple micronutrients, reconstituted as a beverage in 200mL lukewarm water. This will be administered twice a day
Carbohydrate beverage powder
Carbohydrate beverage powder fortified with multiple micronutrients. 20g of study product will be administered orally twice a day
Calorie matched protein powder
20g Calorie matched protein powder with 80% protein, reconstituted as a beverage in 200mL lukewarm water. This will be administered twice a day
Calorie matched beverage powder
Calorie matched beverage powder with 80% protein.20g of study product will be administered orally twice a day
Control
200mL lukewarm water given twice a day
Water
lukewarm water
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carbohydrate beverage powder
Carbohydrate beverage powder fortified with multiple micronutrients. 20g of study product will be administered orally twice a day
Calorie matched beverage powder
Calorie matched beverage powder with 80% protein.20g of study product will be administered orally twice a day
Water
lukewarm water
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good general health
* Non anemic children (Hb≥12 g/dl)
* Academy/development level athlete (at least 3 activity sessions per week, for a minimum of 2 hours of activity in each session e.g. hockey, football, team sports)
Exclusion Criteria
* Allergy/Intolerance to study materials
* History of cardiovascular disorder, respiratory diseases, diabetes mellitus, serious infection/injuries/surgeries (within past 3 months)
* Participation in any nutritional study in past 1 year
* Substance abuse
* Children on any kind of medication in past 1 month of screening
12 Years
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GSK Investigational Site
Pune, , India
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
http://www.i-scholar.in/index.php/Ijnd/article/view/130266
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
203093
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.